A prospective interventional study evaluating the clinical utility of a choice architecture informed questionnaire (AT-CHOICE) for decision support in selecting advanced therapy in patients with ulcerative colitis

A prospective interventional study evaluating the clinical utility of a choice architecture informed questionnaire (AT-CHOICE) for decision support in selecting advanced therapy in patients with ulcerative colitis - AT-CHOICE study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061044

Enrollment

200

Registered

2026-04-01

Start date

2026-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Patients with ulcerative colitis complete a choice architecture informed questionnaire (AT-CHOICE) prior to advanced therapy selection. The questionnaire is administered once, and the responses are sh

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with ulcerative colitis who are scheduled to initiate or switch to advanced therapy and who have provided written informed consent for participation.

Exclusion criteria

Exclusion criteria: Patients who do not provide informed consent for participation.

Design outcomes

Primary

Measure	Time frame
Quality of shared decision making at the time of advanced therapy selection, assessed using the SDM-Q-9	—

Countries

Japan

Contacts

Public ContactShogo Kitahata

Ehime Prefectural Central Hospital Department of Gastroenterology and IBD Center

shogo_kitahata@yahoo.co.jp089-947-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026